Start for free
Start for free
VINCI CAPITAL logo

VINCI CAPITAL

Europe, Vaud, Switzerland, Lausanne

Description

Founded in 2003, Vinci Capital provides equity to Swiss technology and industrial companies and is an independent investment firm.

Investor Profile

VINCI CAPITAL has made 15 investments, with 0 in the past 12 months and 27% as lead.

Stage Focus

  • Series B (27%)
  • Series A (27%)
  • Series Unknown (20%)
  • Post Ipo Equity (13%)
  • Series C (7%)
  • Convertible Note (7%)

Country Focus

  • Switzerland (93%)
  • Germany (7%)

Industry Focus

  • Health Care
  • Biotechnology
  • Medical
  • Personal Health
  • Software
  • Food And Beverage
  • Wellness
  • Emergency Medicine
  • Medical Device
  • Biopharma
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does VINCI CAPITAL frequently co-invest with?

Wellington Partners
Wellington Partners
Europe, Bayern, Germany, Munich
Co-Investments: 6
BioMedPartners
BioMedPartners
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 4
DEFI Gestion
DEFI Gestion
Europe, Vaud, Switzerland, Lausanne
Co-Investments: 2
Novartis Venture Fund
Novartis Venture Fund
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 3
Aravis Ventures
Aravis Ventures
Europe, Zurich, Switzerland, Zürich
Co-Investments: 3
R
Renaissance
Europe, Vaud, Switzerland, Lausanne
Co-Investments: 3
DI
Co-Investments: 2
BlueOcean Ventures
BlueOcean Ventures
Europe, Geneve, Switzerland, Plan-les-ouates
Co-Investments: 2
Swisscom Ventures
Swisscom Ventures
Europe, Zurich, Switzerland, Zürich
Co-Investments: 5
Auriga Partners
Auriga Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 2

What are some of recent deals done by VINCI CAPITAL?

Beqom

Fribourg, Fribourg, Switzerland

Beqom provides a total compensation cloud solution that addresses all aspects of compensation and performance for both sales and HR.

Enterprise SoftwareHuman ResourcesSaaSSoftware
Convertible NoteApr 1, 2014
Amount Raised: $10,600,000
Anergis

Epalinges, Vaud, Switzerland

Anergis discovers and develops allergy vaccines based on the technology of Contiguous Overlapping Peptides for ultra-fast desensitization.

BiotechnologyHealth CareLife ScienceMedicalPersonal Health
Series AFeb 7, 2014
Amount Raised: $8,897,618
SENSIMED

Lausanne, Vaud, Switzerland

Sensimed designs, develops, and commercializes integrated micro-systems for medical devices.

Emergency MedicineHealth CareMedicalMedical DevicePersonal Health
Series COct 9, 2012
Amount Raised: $18,109,303
Anergis

Epalinges, Vaud, Switzerland

Anergis discovers and develops allergy vaccines based on the technology of Contiguous Overlapping Peptides for ultra-fast desensitization.

BiotechnologyHealth CareLife ScienceMedicalPersonal Health
Series AMar 28, 2011
Amount Raised: $20,000,000
SolvAxis

Sonceboz, Bern, Switzerland

SolvAxis is a leader in the design of ERP systems for SMEs .

ConsultingEnterprise Resource Planning (ERP)Software
Series UnknownFeb 2, 2010
Amount Raised: $4,550,000
Evolva

Reinach, Aargau, Switzerland

Evolva is a biotech company that develops and commercializes ready-to-formulate and nature-based ingredients.

BiotechnologyFood and BeverageHealth CareWellness
Series BDec 11, 2009
Amount Raised: $15,518,703
Evolva

Reinach, Aargau, Switzerland

Evolva is a biotech company that develops and commercializes ready-to-formulate and nature-based ingredients.

BiotechnologyFood and BeverageHealth CareWellness
Series BOct 22, 2009
Amount Raised: $27,828,853
Symetis

Ecublens, Vaud, Switzerland

Symetis is a Swiss company developing minimally invasive heart valve replacement therapies for patients suffering from heart valve diseases.

BiotechnologyHealth CareMedical
Series BJul 1, 2009
Amount Raised: $21,300,000
Omnisens SA

Morges, Vaud, Switzerland

Omnisens SA is an oil and gas company located in Morges.

ElectronicsEnergyManufacturingOil and GasOptical CommunicationRenewable Energy
Series UnknownSep 10, 2008
Amount Raised: $5,320,000
SENSIMED

Lausanne, Vaud, Switzerland

Sensimed designs, develops, and commercializes integrated micro-systems for medical devices.

Emergency MedicineHealth CareMedicalMedical DevicePersonal Health
Series ADec 17, 2007
Amount Raised: $6,943,528
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator